Search clinical trials for: CB-839 Capsules
Total 4078 results
-
Calithera Biosciences, IncCompletedHealthy VolunteersUnited States
-
Calithera Biosciences, IncCompletedRenal Cell Carcinoma | Non Small Cell Lung Cancer | Mesothelioma | Solid Tumors | Triple-Negative Breast Cancer | Fumarate Hydratase (FH)-Deficient Tumors | Succinate Dehydrogenase (SDH)-Deficient Gastrointestinal Stromal Tumors (GIST) | Succinate Dehydrogenase (SDH)-Deficient Non-gastrointestinal... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Leptomeningeal Neoplasm | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
Calithera Biosciences, IncCompletedAcute Myeloid Leukemia (AML) | Acute Lymphocytic Leukemia (ALL)United States
-
Calithera Biosciences, IncCompletedMetastatic Renal Cell Carcinoma | Advanced Renal Cell CarcinomaUnited States, United Kingdom, Australia, France, Italy, Germany, Spain, New Zealand
-
Calithera Biosciences, IncCompletedNSCLC | Solid Tumors | KRAS Gene Mutation | CRCUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Acute Myeloid Leukemia With Multilineage Dysplasia | Blasts 20-30 Percent of Bone Marrow Nucleated Cells | Blasts 20-30 Percent of Peripheral Blood White Cells | IPSS Risk Category Intermediate-2United States
-
Beijing Union Pharmaceutical Factory LtdR&G Pharma Studies Co.,Ltd.RecruitingGeneralized Anxiety DisorderChina
-
David BajorActive, not recruitingCB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal CancerColorectal Cancer | Rectal Cancer | Solid Tumor | Colon CancerUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); Calithera Biosciences, IncNot yet recruitingCervical Cancer | Cervix Cancer | Advanced Cervical Carcinoma | Cancer of the CervixUnited States
-
Tallikut Pharmaceuticals, Inc.Completed
-
Calithera Biosciences, IncCompletedMultiple Myeloma | Non-Hodgkin's Lymphoma (NHL) | Waldenstrom's Macroglobulinemia (WM) | Other B-cell NHL Subtypes, Including WM | T-cell NHLUnited States
-
Massachusetts General HospitalPfizer; Prostate Cancer Foundation; Calithera Biosciences, IncNot yet recruiting
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
Shanghai Jiao Tong University School of MedicineShanghai Chest HospitalRecruiting
-
Reata, a wholly owned subsidiary of BiogenCompletedMelanoma | Unresectable (Stage III) Melanoma | Metastatic (Stage IV) MelanomaUnited States
-
Calithera Biosciences, IncCompletedClear Cell Renal Cell CarcinomaUnited States
-
Calithera Biosciences, IncTerminatedMelanoma | Non-small Cell Lung Cancer (NSCLC) | Clear Cell Renal Cell Carcinoma (ccRCC)United States
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Altor BioScienceGenentech, Inc.; TanoxCompletedSepsis | Acute Respiratory Distress Syndrome | Acute Lung InjuryUnited States, Canada
-
Calithera Biosciences, IncCompletedTriple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
University of MinnesotaRecruitingCannabis Use DisorderUnited States
-
Hongsheng TanShanghai Shen Kang Hospital Development Center; Longhua Hospital; Hongqiao International...Completed
-
CymaBay Therapeutics, Inc.Completed
-
NeuroActiva, Inc.CompletedNeurocognitive Disorders | Neurodegenerative Diseases | Cognitive Impairment | Alzheimer Disease | Tauopathies | Mild Cognitive Impairment | Dementia, Vascular | Dementia With Lewy Bodies | Alzheimer Dementia | Cognitive DisorderNew Zealand
-
Altor BioScienceNational Heart, Lung, and Blood Institute (NHLBI)CompletedSepsis | Acute Respiratory Distress Syndrome | Acute Lung InjuryUnited States
-
Enzychem Lifesciences CorporationCompleted
-
National Cancer Institute (NCI)WithdrawnLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Aggressive Non-Hodgkin Lymphoma | Indolent Non-Hodgkin LymphomaUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingDry Age-related Macular DegenerationItaly
-
University of Alabama at BirminghamTerminatedOvarian Cancer | Resistant BRCA Wild-Type Ovarian CancerUnited States
-
Fate TherapeuticsTerminatedHematologic MalignanciesUnited States
-
OPKO Health, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Vitamin D InsufficiencyUnited States
-
Calithera Biosciences, IncTerminatedClear Cell Renal Cell Carcinoma | Colorectal Cancer | Solid Tumor | CRC | TNBC - Triple-Negative Breast Cancer | ccRCC | RCCUnited States
-
Cleave Therapeutics, Inc.CompletedMyelodysplastic Syndromes | Acute Myeloid Leukemia, in RelapseUnited States, Australia
-
First Affiliated Hospital Xi'an Jiaotong UniversityUnknownFibrocystic Disease of BreastChina
-
Calithera Biosciences, IncNovotech (Australia) Pty LimitedCompleted
-
University of ZurichRecruitingLung Transplant Rejection | Lung Transplant Failure and RejectionSwitzerland
-
TaiRx, Inc.CompletedAdvanced CancerTaiwan
-
Psychiatric Hospital of the University of BaselTerminated
-
Cleave Biosciences, Inc.TerminatedAdvanced Solid TumorsUnited States
-
Medtronic - MITGTerminated
-
Beijing Tiantan HospitalNeuroDawn Pharmaceutical Co., Ltd.RecruitingIschemic Stroke, AcuteChina
-
Massachusetts General HospitalCenter for Microbiome Informatics and TherapeuticsActive, not recruitingHepatic EncephalopathyUnited States
-
Han YalingCompletedCoronary Artery DiseaseChina
-
POM Wonderful LLCCompletedRecurrent Prostate CancerUnited States
-
Natrogen Therapeutics International, IncUnknownUlcerative ColitisUnited States
-
Calithera Biosciences, IncTerminatedNon-GCB/ABC Diffuse Large B-Cell Lymphoma | With and Without MyD88 and/or CD79B MutationsUnited States
-
Applied Genetic Technologies CorpOregon Health and Science University; University of Massachusetts, WorcesterCompletedLeber Congenital AmaurosisUnited States
-
National Center for Research Resources (NCRR)University of North CarolinaCompleted
-
National Cancer Institute (NCI)Active, not recruitingAstrocytoma, IDH-Mutant, Grade 2 | Astrocytoma, IDH-Mutant, Grade 3United States